468

According to data obtained from SmartTrak Medical Device and Wound Market Intelligence, in the third quarter of 2024 (Q324), the US Skin Substitute / Cellular Tissue Product (CTP) market reached $1.75 BILLION. That figure is up 64.0% compared to the third quarter of 2023 (Q323) – one year ago. Amniotic products held the vast majority of the US market at 79.1% share, up from 73.3% in Q323.

The opinions, comments, and content expressed or implied in my statements are solely my own and do not necessarily reflect the position or views of Intellicure or any of the boards on which I serve.